News
I
Mar 10, 2021
Geniebiome collaborates with CUHK on clinical trial to study the impact of a microbiome immunity for
Study aims to evaluate in elderlies and patients with type 2 diabetes, the impact of G-NiiB Immunity Pro (SIM02) in reduction of vaccine-related adverse reactions and improvement of COVID-19 vaccine efficacy
-0.jpg)
.jpg)
